
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GILD | NASDAQ | USD | Real-time | |
GILD | Mexico | MXN | Delayed | |
GGILD | Milan | EUR | Real-time | |
GILD | Xetra | EUR | Delayed | |
GILD | Frankfurt | EUR | Delayed | |
GILD | TradeGate | EUR | Delayed | |
GILD | Santiago | USD | Delayed | |
GILDCL | Santiago | CLP | Delayed | |
GILD | Buenos Aires | ARS | Delayed | |
GILD | Vienna | EUR | Delayed |
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Monday, September 14th. Please refresh for updates. Oracle (NYSE:ORCL) stock rose 7.5% after reports that the tech giant has...
By Peter Nurse Investing.com - U.S. stocks are set to open higher Monday, seeking a fresh start after last week’s tech-inspired selloff. Positive Covid vaccine news and M&A deals are driving the...
By Geoffrey Smith Investing.com -- Oracle (NYSE:ORCL) wins the race for TikTok's U.S. operations, Nvidia (NASDAQ:NVDA) splashes out $40 billion to buy ARM from Softbank (OTC:SFTBY), while Gilead bets...
(Reuters) - Gilead Sciences Inc (O:GILD) will acquire biopharmaceutical company Immunomedics Inc (O:IMMU) for $21 billion, a move that will strengthen its cancer portfolio by gaining access to a...
(Reuters) - Gilead Sciences Inc (O:GILD) is nearing a deal to buy biopharmaceutical company Immunomedics Inc (O:IMMU) for more than $20 billion in a deal that would further expand Gilead's...
By Deena Beasley (Reuters) - U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir since July as need for the costly antiviral wanes, according to...
By Caroline Humer (Reuters) - As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead...
By Geoffrey Smith and Christiana Sciaudone Investing.com -- It's been a rough week for Gilead. The Federal Drug Administration shocked the pharmaceutical maker and its shareholders when it rejected an...
By Geoffrey Smith Investing.com -- Onno van de Stolpe named his biotech startup after a chain of islands famed for the diversity and inventiveness of its wildlife. It’s ironic, then, that the market...
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Oil & Gas, Consumer Services and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review